HighTide Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
HighTide Therapeutics has a total shareholder equity of CN¥702.8M and total debt of CN¥3.5M, which brings its debt-to-equity ratio to 0.5%. Its total assets and total liabilities are CN¥795.0M and CN¥92.3M respectively.
Key information
0.5%
Debt to equity ratio
CN¥3.50m
Debt
Interest coverage ratio | n/a |
Cash | CN¥735.70m |
Equity | CN¥702.77m |
Total liabilities | CN¥92.26m |
Total assets | CN¥795.04m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2511's short term assets (CN¥778.8M) exceed its short term liabilities (CN¥79.8M).
Long Term Liabilities: 2511's short term assets (CN¥778.8M) exceed its long term liabilities (CN¥12.5M).
Debt to Equity History and Analysis
Debt Level: 2511 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 2511's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if 2511 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 2511 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.